https://www.srxglobalinc.com/news-events/press-releases/rss en-us https://d1io3yog0oux5.cloudfront.net/srxhealth/files/theme/images/logo-sm.png Equisolve Investor Relations Suite https://www.srxglobalinc.com/news-events/press-releases/detail/155/srx-global-provides-update-on-balance-sheet-and-share-buyback Fri, 30 Oct 26 15:16:00 -0400 https://www.srxglobalinc.com/news-events/press-releases/detail/155/srx-global-provides-update-on-balance-sheet-and-share-buyback https://www.srxglobalinc.com/news-events/press-releases/detail/154/srx-global-announces-activation-of-the-university-of-california-davis-as-a-clinical-trial-site-for-cero-therapeutics-ongoing-phase-1-certain-t-trial-of-cer-1236-in-hematologic-malignancies Mon, 26 Oct 26 09:05:00 -0400 https://www.srxglobalinc.com/news-events/press-releases/detail/154/srx-global-announces-activation-of-the-university-of-california-davis-as-a-clinical-trial-site-for-cero-therapeutics-ongoing-phase-1-certain-t-trial-of-cer-1236-in-hematologic-malignancies https://www.srxglobalinc.com/news-events/press-releases/detail/153/srx-global-commits-2-5-million-to-launch-multi-strategy-trading-platform-in-partnership-with-5t-trading-powered-by-the-emjx-platform Thu, 08 Oct 26 08:35:00 -0400 https://www.srxglobalinc.com/news-events/press-releases/detail/153/srx-global-commits-2-5-million-to-launch-multi-strategy-trading-platform-in-partnership-with-5t-trading-powered-by-the-emjx-platform https://www.srxglobalinc.com/news-events/press-releases/detail/152/srx-global-and-cero-1236-a-wholly-owned-spv-enter-into-definitive-agreement-to-acquire-cero-therapeutics-an-innovative-cellular-immunotherapy-company-developing-cer-1236-for-hematologic-malignancies Wed, 07 Oct 26 15:00:00 -0400 https://www.srxglobalinc.com/news-events/press-releases/detail/152/srx-global-and-cero-1236-a-wholly-owned-spv-enter-into-definitive-agreement-to-acquire-cero-therapeutics-an-innovative-cellular-immunotherapy-company-developing-cer-1236-for-hematologic-malignancies https://www.srxglobalinc.com/news-events/press-releases/detail/151/srx-global-commits-1-5-million-to-launch-family-of-ai-powered-etfs-through-its-emjx-platform-partnering-with-kupa-ai-co-founder-andy-kim Tue, 06 Oct 26 16:20:00 -0400 https://www.srxglobalinc.com/news-events/press-releases/detail/151/srx-global-commits-1-5-million-to-launch-family-of-ai-powered-etfs-through-its-emjx-platform-partnering-with-kupa-ai-co-founder-andy-kim https://www.srxglobalinc.com/news-events/press-releases/detail/150/srx-global-provides-shareholders-with-update-on-liquidation-of-two-portfolio-investments-and-adds-an-investment-in-onconetix-nasdaq-onco Thu, 24 Sep 26 12:30:00 -0400 https://www.srxglobalinc.com/news-events/press-releases/detail/150/srx-global-provides-shareholders-with-update-on-liquidation-of-two-portfolio-investments-and-adds-an-investment-in-onconetix-nasdaq-onco https://www.srxglobalinc.com/news-events/press-releases/detail/149/srx-global-ceo-kent-cunningham-and-president-of-emjx-platform-eric-jackson-to-present-at-webull-corporate-connect-series-fintech-investment-webinar Wed, 23 Sep 26 16:05:00 -0400 https://www.srxglobalinc.com/news-events/press-releases/detail/149/srx-global-ceo-kent-cunningham-and-president-of-emjx-platform-eric-jackson-to-present-at-webull-corporate-connect-series-fintech-investment-webinar https://www.srxglobalinc.com/news-events/press-releases/detail/148/srx-global-provides-shareholder-update-on-portfolio-company-armr-sciences-a-clinical-stage-biodefense-company Thu, 03 Sep 26 08:15:00 -0400 https://www.srxglobalinc.com/news-events/press-releases/detail/148/srx-global-provides-shareholder-update-on-portfolio-company-armr-sciences-a-clinical-stage-biodefense-company https://www.srxglobalinc.com/news-events/press-releases/detail/147/srx-global-acquires-senior-secured-debt-in-cero-therapeutics-holdings-inc-an-innovative-cellular-immunotherapy-company-with-cancer-fighting-molecule-for-the-treatment-of-hematologic-cancers Mon, 31 Aug 26 07:30:00 -0400 https://www.srxglobalinc.com/news-events/press-releases/detail/147/srx-global-acquires-senior-secured-debt-in-cero-therapeutics-holdings-inc-an-innovative-cellular-immunotherapy-company-with-cancer-fighting-molecule-for-the-treatment-of-hematologic-cancers https://www.srxglobalinc.com/news-events/press-releases/detail/146/srx-global-inc-announces-fiscal-third-quarter-2026-financial-results Thu, 13 Aug 26 16:05:00 -0400 https://www.srxglobalinc.com/news-events/press-releases/detail/146/srx-global-inc-announces-fiscal-third-quarter-2026-financial-results